Exagen Inc. to Participate in Upcoming Investor Conference
Exagen Inc. announced its management team will participate in the Canaccord Genuity 46th Annual Growth Conference with a fireside chat scheduled for August 11, 2026. The event will be webcast live and archived for investors. Exagen is a Nasdaq-listed company specializing in autoimmune diagnostics and aims to transform patient care by offering innov…